SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000878088-12-000024
Filing Date
2012-02-02
Accepted
2012-02-02 16:46:52
Documents
5
Period of Report
2012-02-02
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K/A form8kaanchenfeb12012.htm 8-K/A 31641
2 CONSENT exhibit23melbyconsent.htm EX-23.1 1795
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS ex991anchenfinancial20082010.htm EX-99.1 779272
4 CONDENSED CONSOLIDATED FINANCIAL STATEMENTS exhibit992financialstat20102.htm EX-99.2 287790
5 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS exhibit993proformafeb22012.htm EX-99.3 461806
  Complete submission text file 0000878088-12-000024.txt   1563527
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-10827 | Film No.: 12566469
SIC: 2834 Pharmaceutical Preparations